blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1690937

EP1690937 - METHOD OF CONSTRUCTING TRANSGENIC DENDRITIC CELL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.08.2013
Database last updated on 25.09.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Dnavec Research Inc.
25-11 Kannondai 1-chome Tsukuba-shi
Ibaraki 305-0856 / JP
[2006/33]
Inventor(s)01 / OKANO, Shinji
15-3-301, Yoshizuka 4-chome
Hakata-ku
Fukuoka-shi, Fukuoka 812-0041 / JP
02 / YONEMITSU, Yoshikazu
5-31-3, Najima
Higashi-ku
Fukuoka-shi, Fukuoka 813-0043 / JP
03 / SUEISHI, Katsuo
1-29-22, Oike
Minami-ku
Fukuoka-shi, Fukuoka 815-0073 / JP
04 / SHIBATA, Satoko
2-14-15-701, Hakomatsu
Higashi-ku
Fukuoka-shi, Fukuoka 812-0061 / JP
05 / HASEGAWA, Mamoru, c/o DNAVEC RESEARCH INC.
25-11, Kannondai 1-chome
Tsukuba-shi, Ibaraki 305-0856 / JP
 [2012/42]
Former [2006/33]01 / OKANO, Shinji
15-3-301, Yoshizuka 4-chome, Hakata-ku
Fukuoka-shi, Fukuoka 812-0041 / JP
02 / YONEMITSU, Yoshikazu
5-31-3, Najima, Higashi-ku
Fukuoka-shi, Fukuoka 813-0043 / JP
03 / SUEISHI, Katsuo
1-29-22, Oike, Minami-ku
Fukuoka-shi, Fukuoka 815-0073 / JP
04 / SHIBATA, Satoko
2-14-15-701, Hakomatsu, Higashi-ku
Fukuoka-shi, Fukuoka 812-0061 / JP
05 / HASEGAWA, Mamoru, c/o DNAVEC RESEARCH INC.
25-11, Kannondai 1-chome
Tsukuba-shi, Ibaraki 305-0856 / JP
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2012/42]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Former [2006/33]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date04793197.729.10.2004
[2006/33]
WO2004JP16089
Priority number, dateJP2003037480804.11.2003         Original published format: JP 2003374808
JP2004018702824.06.2004         Original published format: JP 2004187028
[2006/33]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005042737
Date:12.05.2005
Language:EN
[2005/19]
Type: A1 Application with search report 
No.:EP1690937
Date:16.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 12.05.2005 takes the place of the publication of the European patent application.
[2006/33]
Type: B1 Patent specification 
No.:EP1690937
Date:17.10.2012
Language:EN
[2012/42]
Search report(s)International search report - published on:JP12.05.2005
(Supplementary) European search report - dispatched on:EP06.12.2006
ClassificationIPC:C12N15/09, C12N5/16, A61K39/00, A61K48/00, A61P35/00
[2006/33]
CPC:
C12N15/86 (EP,KR,US); A61K39/4615 (EP,KR); A61K39/4622 (EP,KR);
A61K39/464456 (EP,KR); A61K39/464491 (EP,KR); A61K39/464499 (EP,KR);
A61P31/00 (EP); A61P35/00 (EP); C12N5/16 (KR);
A61K2039/5156 (US); A61K2239/57 (EP,KR); C12N2510/02 (EP,US);
C12N2760/18843 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/33]
TitleGerman:VERFAHREN ZUR KONSTRUKTION EINER TRANSGENEN DENDRITISCHEN ZELLE[2006/33]
English:METHOD OF CONSTRUCTING TRANSGENIC DENDRITIC CELL[2006/33]
French:METHODE DE CONSTRUCTION D'UNE CELLULE DENDRITIQUE TRANSGENIQUE[2006/33]
MiscellaneousEPB 2006/33: The applicant has requested a correction according to Rule 88 EPC
Entry into regional phase30.05.2006Translation filed 
30.05.2006National basic fee paid 
30.05.2006Search fee paid 
30.05.2006Designation fee(s) paid 
30.05.2006Examination fee paid 
Examination procedure13.05.2005Request for preliminary examination filed
International Preliminary Examining Authority: JP
30.05.2006Amendment by applicant (claims and/or description)
30.05.2006Examination requested  [2006/33]
26.07.2007Despatch of a communication from the examining division (Time limit: M06)
11.01.2008Reply to a communication from the examining division
13.05.2008Despatch of a communication from the examining division (Time limit: M04)
19.09.2008Reply to a communication from the examining division
03.11.2008Despatch of a communication from the examining division (Time limit: M06)
13.05.2009Reply to a communication from the examining division
22.07.2009Despatch of a communication from the examining division (Time limit: M06)
20.01.2010Reply to a communication from the examining division
23.03.2010Despatch of a communication from the examining division (Time limit: M06)
04.10.2010Reply to a communication from the examining division
09.11.2010Despatch of a communication from the examining division (Time limit: M06)
19.05.2011Reply to a communication from the examining division
29.02.2012Cancellation of oral proceeding that was planned for 06.03.2012
06.03.2012Date of oral proceedings (cancelled)
28.03.2012Communication of intention to grant the patent
02.08.2012Fee for grant paid
02.08.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.07.2007
Opposition(s)18.07.2013No opposition filed within time limit [2013/39]
Fees paidRenewal fee
30.05.2006Renewal fee patent year 03
30.10.2007Renewal fee patent year 04
20.03.2008Renewal fee patent year 05
27.10.2009Renewal fee patent year 06
25.10.2010Renewal fee patent year 07
20.10.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.10.2004
AT17.10.2012
BE17.10.2012
CY17.10.2012
CZ17.10.2012
DK17.10.2012
EE17.10.2012
FI17.10.2012
IT17.10.2012
NL17.10.2012
PL17.10.2012
RO17.10.2012
SI17.10.2012
SK17.10.2012
TR17.10.2012
IE29.10.2012
LU29.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
BG17.01.2013
GR18.01.2013
ES28.01.2013
PT18.02.2013
[2014/34]
Former [2014/27]AT17.10.2012
BE17.10.2012
CY17.10.2012
CZ17.10.2012
DK17.10.2012
EE17.10.2012
FI17.10.2012
IT17.10.2012
NL17.10.2012
PL17.10.2012
RO17.10.2012
SI17.10.2012
SK17.10.2012
TR17.10.2012
IE29.10.2012
LU29.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
BG17.01.2013
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2014/21]AT17.10.2012
BE17.10.2012
CY17.10.2012
CZ17.10.2012
DK17.10.2012
EE17.10.2012
FI17.10.2012
IT17.10.2012
NL17.10.2012
PL17.10.2012
RO17.10.2012
SI17.10.2012
SK17.10.2012
TR17.10.2012
IE29.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
BG17.01.2013
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2013/47]AT17.10.2012
BE17.10.2012
CY17.10.2012
CZ17.10.2012
DK17.10.2012
EE17.10.2012
FI17.10.2012
IT17.10.2012
NL17.10.2012
PL17.10.2012
RO17.10.2012
SI17.10.2012
SK17.10.2012
IE29.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
BG17.01.2013
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2013/37]AT17.10.2012
BE17.10.2012
CY17.10.2012
CZ17.10.2012
DK17.10.2012
EE17.10.2012
FI17.10.2012
IT17.10.2012
NL17.10.2012
PL17.10.2012
RO17.10.2012
SI17.10.2012
SK17.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
BG17.01.2013
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2013/35]AT17.10.2012
BE17.10.2012
CY17.10.2012
CZ17.10.2012
DK17.10.2012
EE17.10.2012
FI17.10.2012
NL17.10.2012
PL17.10.2012
SI17.10.2012
SK17.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
BG17.01.2013
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2013/34]AT17.10.2012
BE17.10.2012
CY17.10.2012
DK17.10.2012
FI17.10.2012
NL17.10.2012
PL17.10.2012
SI17.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
BG17.01.2013
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2013/33]AT17.10.2012
BE17.10.2012
CY17.10.2012
FI17.10.2012
NL17.10.2012
PL17.10.2012
SI17.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2013/31]AT17.10.2012
BE17.10.2012
CY17.10.2012
FI17.10.2012
NL17.10.2012
PL17.10.2012
SI17.10.2012
MC31.10.2012
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2013/28]BE17.10.2012
CY17.10.2012
FI17.10.2012
NL17.10.2012
PL17.10.2012
SI17.10.2012
MC31.10.2012
GR18.01.2013
ES28.01.2013
PT18.02.2013
Former [2013/26]BE17.10.2012
CY17.10.2012
FI17.10.2012
NL17.10.2012
PL17.10.2012
SI17.10.2012
MC31.10.2012
GR18.01.2013
ES28.01.2013
Former [2013/24]BE17.10.2012
CY17.10.2012
FI17.10.2012
NL17.10.2012
PL17.10.2012
MC31.10.2012
GR18.01.2013
ES28.01.2013
Former [2013/23]CY17.10.2012
FI17.10.2012
NL17.10.2012
PL17.10.2012
ES28.01.2013
Former [2013/22]FI17.10.2012
NL17.10.2012
ES28.01.2013
Documents cited:Search[Y]EP1186667  (DNAVEC RESEARCH INC [JP]) [Y] 13,14 * Page 2 lines 31-35 *;
 [Y]  - JIN CH ET AL, "Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem Cells", GENE THERAPY, MACMILLAN PRESS LTD., BASINGSTOKE, GB, (200302), vol. 10, no. 3, ISSN 0969-7128, pages 272 - 277, XP002983185 [Y] 1-14 * Abstract Page 274 col 1 lines 1-15 *

DOI:   http://dx.doi.org/10.1038/sj.gt.3301877
 [Y]  - CREMER I ET AL, "Inhibition of human immunodeficiency virus transmission to CD4+ T cells after gene transfer of constitutively expressed interferon beta to dendritic cells", HUMAN GENE THERAPY, (20000810), vol. 11, no. 12, ISSN 1043-0342, pages 1695 - 1703, XP002406342 [Y] 1-12 * Abstract Page 1696 col 2 lines 33-50 *

DOI:   http://dx.doi.org/10.1089/10430340050111340
 [Y]  - STEITZ J ET AL, "Depletion of CD25+ CD4+ T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8+ T-cell-dependent immune defense of B16 melanoma", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (20011215), vol. 61, no. 24, ISSN 0008-5472, pages 8643 - 8646, XP002396933 [Y] 13,14 * Abstract *
 [A]  - STEINMAN R M, "DENDRITIC CELLS AND IMMUNE-BASED THERAPIES", EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, (199607), vol. 24, no. 8, ISSN 0301-472X, pages 859 - 862, XP000999716 [A] 1-14 * Abstract Page 859 col 2 lines 33-40 *
International search[Y]  - JIN, CH. ET AL., "Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem Cells", GENE THER., (200302), vol. 10, no. 3, pages 272 - 277, XP002983185

DOI:   http://dx.doi.org/10.1038/sj.gt.3301877
 [Y]  - JONULEIT, H. ET AL., "Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity", GENE THER., (2000), vol. 7, no. 3, pages 249 - 254, XP002983186

DOI:   http://dx.doi.org/10.1038/sj.gt.3301077
 [Y]  - SUMIMOTO, H. ET AL., "Rapid and efficient generation of lentivirally gene-modified dendritic cells from DC progenitors with bone marrow stromal cells", J IMMUNOL METHODS, (2002), vol. 271, no. 1-2, pages 153 - 165, XP004393934

DOI:   http://dx.doi.org/10.1016/S0022-1759(02)00342-3
 [Y]  - LUNDQVIST, A. ET AL., "Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection", J IMMUNOTHER., (2002), vol. 25, no. 6, pages 445 - 454, XP002983187

DOI:   http://dx.doi.org/10.1097/00002371-200211000-00001
 [Y]  - OKANO, S. ET AL., "Recombinant Sendai virus vectors for activated T lymphocytes", GENE THER., (200308), vol. 10, no. 16, pages 1381 - 1391, XP002973825

DOI:   http://dx.doi.org/10.1038/sj.gt.3301998
 [A]  - SASAKI, K. ET AL., "Efficient and stable Sendai virus-mediated gene transfer into primate embryonic cells with pluripotency preserved", GENE THER., (2003), vol. 10, pages 1381 - 1391, XP002973825

DOI:   http://dx.doi.org/10.1038/sj.gt.3301998
by applicantJPS6230752B
 JPS6230753B
 JPS6233879B
 JPS6474982
 JPH01285498
 JPH05192160
 JPH05252965
 JPH07502173
 WO9716539
 WO9716538
 WO9732010
 US5744144
 US5798100
 WO0070055
 WO0070070
 EP1067179
 WO0104272
    - MOL. THER., (2002), pages 283 - 290
    - J IMMUNOTHERAPY, (2002), vol. 25, pages 445 - 454
    - GENE THERAPY, (2000), vol. 7, pages 249 - 254
    - "Paramyxoviridae: The viruses and their replication", LAMB, R.A.; KOLAKOFSKY, D., Fields of Virology, LIPPINCOTT - RAVEN PUBLISHERS, (1996), vol. 2, pages 1177 - 1204
    - YU, D. ET AL., GENES CELLS, (1997), vol. 2, pages 457 - 466
    - HASAN, M. K. ET AL., J. GEN. VIROL., (1997), vol. 78, pages 2813 - 2820
    - KATO, A. ET AL., EMBO J., (1997), vol. 16, pages 578 - 587
    - GRAHAM, F. L.; VAN DER EB, J., VIROLOGY, (1973), vol. 52, page 456
    - WIGLER, M.; SILVERSTEIN, S., CELL, (1977), vol. 11, page 223
    - CHEN, C.; OKAYAMA, H., MOL. CELL. BIOL., (1987), vol. 7, page 2745
    - CALOS, M. P., PROC. NATL. ACAD. SCI. USA, (1983), vol. 80, page 3015
    - PROC. NATL. ACAD. SCI. USA, (1983), vol. 80, page 3015
    - KATO, A. ET AL., GENES CELLS, (1996), vol. 1, pages 569 - 579
    - "Hemaggulutinating virus of Japan-liposome-mediated gene delivery to vascular cells", YONEMITSU, Y; KANEDA, Y, Molecular Biology of Vascular Diseases. Method in Molecular Medicine, HUMANA PRESS, (1999), pages 295 - 306
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.